You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Figure INF-3:  HIV prevalence among injecting drug users – studies with national and subnational coverage, 2002 to 2003

Figure INF-03

Notes:

Black square = samples with national coverage; blue triangle = samples with subnational (including local or regional) coverage.

Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Data for Portugal and Italy and part of the data for Czech Republic and France include non-IDUs and therefore may underestimate prevalence among IDUs (estimated proportion of non-IDUs in the samples: Italy 5-10%, Czech Republic, France and Portugal not known).

Data for Italy, Portugal and Slovakia are limited to prevalence among IDUs in treatment and may not be representative of prevalence among IDUs who are not in treatment.

Data for Luxembourg, and part of the data for Belgium, Czech Republic, France and Hungary, are based on self-reported test results, which are less reliable than clinically documented tests.

Sources:

Reitox national focal points. For primary sources, study details and data before 2002, see [Table INF-8] in the 2005 statistical bulletin.